Affiliation:
1. Center of Clinical Pharmacology, Third Xiangya Hospital; Central South University; Changsha Hunan 410013 China
2. School of Pharmaceutical Sciences; Central South University; Changsha Hunan 410013 China
Funder
the Program for Science and Technology Research of Hunan Province
the Health Department Foundation of Hunan Province
the National Science and Technology Major Projects
the National Scientif ic Foundation of China
Subject
Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Biology,General Medicine,Biochemistry,Analytical Chemistry
Reference17 articles.
1. China Food and Drug Administration Technical Guidelines: Human Bioavailability and Bioequivalence Study of Chemico-pharmaceutical Preparations 2005 http://www.sfda.gov.cn/directory/web/WS01/images/u6Rp9KpzuWxrzByMvM5cn6zuA+9PDtsi6zcn6zu+1yNCn0NTR0L6vLzK9da4tbzUrdTyLnBkZg==.pdf
2. Binding of dimemorfan to sigma-1 receptor and its anticonvulsant and locomotor effects in mice, compared with dextromethorphan and dextrorphan;Chou;Brain Research,1999
3. Dimemorfan N-demethylation by mouse liver microsomal cytochrome P450 enzymes;Chou;Life Sciences,2005
4. The oxidative metabolism of dimemorfan by human cytochrome P450 enzymes;Chou;Journal of Pharmaceutical Sciences,2010
5. European Medicines Agency Guideline on Validation of Bioanalytical Methods 2011 http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2011/08/WC500109686.pdf